1,4-dihydropyridine has been researched along with Cardiomyopathy, Hypertrophic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Catterall, WA; Fu, Y; Scheuer, T; Westenbroek, RE | 1 |
| Haase, H; Hohaus, A; Kresse, A; Lange, PE; Maier, M; Morano, I; Osterziel, KJ; Schulte, HD | 1 |
2 other study(ies) available for 1,4-dihydropyridine and Cardiomyopathy, Hypertrophic
| Article | Year |
|---|---|
Basal and β-adrenergic regulation of the cardiac calcium channel CaV1.2 requires phosphorylation of serine 1700.
Topics: Adaptation, Physiological; Adrenergic beta-Agonists; Amino Acid Substitution; Animals; Arrhythmias, Cardiac; Barium; Calcium; Calcium Channels, L-Type; Cardiomyopathy, Hypertrophic; Casein Kinase II; Dihydropyridines; Exercise Tolerance; Heart Failure; Ion Transport; Isoproterenol; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Models, Molecular; Mutation, Missense; Myocardial Contraction; Myocytes, Cardiac; Phosphorylation; Phosphoserine; Point Mutation; Protein Conformation; Protein Processing, Post-Translational; Receptors, Adrenergic, beta; Signal Transduction; Transfection | 2014 |
Expression of calcium channel subunits in the normal and diseased human myocardium.
Topics: Amino Acid Sequence; Binding Sites; Calcium Channels; Calcium Channels, L-Type; Cardiomyopathy, Hypertrophic; Dihydropyridines; Humans; Molecular Sequence Data; Myocardium | 1996 |